In nasopharyngeal carcinoma (NPC), YTHDC2 increased the translation efficiency and expression of IGF1R mRNA, thereby activating the downstream PI3K-AKT/S6 pathway, inhibiting tumor cell apoptosis, stimulating protein synthesis, and promoting radiotherapy resistance. The gene discussed is YTHDC2; the disease is nasopharyngeal carcinoma.